Progressive encephalopathy in m.3243A > G/MT-TL1 mutation carriers: a quantitative EEG analysis

Clin Neurophysiol. 2025 Sep:177:2110822. doi: 10.1016/j.clinph.2025.2110822. Epub 2025 Jun 26.

Abstract

Objective: The m.3243A > G/MT-TL1 mutation underlies a broad spectrum of clinical manifestations, varying from the mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome to incomplete phenotypes without stroke-like episodes (SLE), termed MELAS-Spectrum Syndrome (MSS). We systematically analyzed the longitudinal EEG changes in individuals carrying the m.3243A > G/MT-TL1 mutation through visual inspection of paroxysmal abnormalities and quantitative analysis of background activity.

Methods: Adults with the m.3243A > G/MT-TL1 mutation and at least two EEG recordings during their follow-up were included. For each EEG, we obtained: 1) delta-theta/alpha energy ratio (ER); 2) Higuchi fractal dimension (HD); 3) paroxysmal activities (AR), quantified by two experienced clinicians. A linear mixed model assessed the effect of early SLE phases as a time-dependent covariate.

Results: Sixteen patients (9 females) were recruited. ER significantly increased over time in temporal-parieto-occipital regions. EEG traces recorded shortly after SLEs showed significantly higher ER, lower HD, and an increasing AR trend.

Conclusions: Quantitative EEG metrics revealed a gradual disruption of posterior background rhythms in both MSS and MELAS. Early consequences of SLEs include background activity slowing, reduction of brain states complexity, and recrudescence of paroxysmal abnormalities.

Significance: Neurophysiological signs of progressive brain dysfunction emerged in all individuals with m.3243A > G/MT-TL1 mutation, independently of SLEs.

Keywords: Fractal dimension; Quantitative EEG; m.3243A>G/MT-TL1 mutation.

MeSH terms

  • Adult
  • DNA, Mitochondrial* / genetics
  • Disease Progression
  • Electroencephalography* / methods
  • Female
  • Heterozygote
  • Humans
  • MELAS Syndrome* / diagnosis
  • MELAS Syndrome* / genetics
  • MELAS Syndrome* / physiopathology
  • Male
  • Middle Aged
  • Mutation* / genetics
  • RNA, Transfer, Leu* / genetics
  • Young Adult

Substances

  • MT-TL1 tRNA, human
  • RNA, Transfer, Leu
  • DNA, Mitochondrial